The earnings call reflects a positive outlook for OmniAb with strong growth in deals and programs, a successful launch of a new product line, and increased revenue. However, challenges such as net losses and lower royalty revenues persist. Overall, the positives in terms of strategic growth and financial performance outweigh the negatives.

Company Guidance -

Q3 2025

During OmniAb, Inc.'s first-quarter 2025 financial results call, the company provided optimistic guidance fueled by strong deal flow, adding new partners, and achieving a notable 95 active partners by the end of the quarter. OmniAb's pipeline grew to 378 active programs, despite natural attrition in drug development, with 33 active clinical programs and approved products reported. The launch of the exploration partner access program was a significant milestone, offering partners the ability to integrate the exploration instrument into their workflows, potentially generating new revenue streams. Financially, the company reported a 10.5% increase in revenue to $4.2 million, attributed to higher milestone revenue, though the net loss for the quarter was $18.2 million. OmniAb maintained its 2025 revenue guidance of $20-25 million, excluding contributions from the exploration program, and revised its operating expense guidance to $85-90 million, down from $90-95 million.

Strong Start to 2025

2025 is off to a very good start with strong deal flow, both platform and asset-based, and a growing pipeline of partnered programs.

Launch of Exploration Partner Access Program

OmniAb launched the exploration partner access program, allowing partners to purchase exploration instruments for use in their labs, creating new revenue streams.

Increase in Active Partners and Programs

Exited Q1 with 95 active partners and 378 active programs, showing continued growth in partner and program metrics.

Revenue Increase

Q1 2025 revenue increased to $4.2 million from $3.8 million in Q1 2024, mainly due to higher milestone revenue.

Reduction in Operating Expenses

Operating expenses declined to $23 million from $26.4 million in the prior year period, with cost savings in R&D and G&A.

Upcoming Presentations and Conferences

OmniAb will be showcasing exploration at the PEGs conference in Boston and ASCO annual meeting in Chicago.

OmniAb (OABI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OABI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 18, 2025	2025 (Q3)	-0.14 / -	-0.16	―	―	―
Aug 06, 2025	2025 (Q2)	-0.15 / -0.15	-0.13	-15.38% (-0.02)
May 08, 2025	2025 (Q1)	-0.16 / -0.17	-0.19	10.53% (+0.02)
Mar 18, 2025	2024 (Q4)	-0.11 / -0.12	-0.14	14.29% (+0.02)
Nov 12, 2024	2024 (Q3)	-0.14 / -0.16	-0.16	0.00% (0.00)
Aug 08, 2024	2024 (Q2)	-0.17 / -0.13	-0.15	13.33% (+0.02)
May 09, 2024	2024 (Q1)	-0.16 / -0.19	-0.06	-216.67% (-0.13)
Mar 20, 2024	2023 (Q4)	-0.14 / -0.14	0.07	-300.00% (-0.21)
Nov 09, 2023	2023 (Q3)	-0.14 / -0.16	-0.285	43.86% (+0.12)
Aug 10, 2023	2023 (Q2)	-0.12 / -0.15	-0.03	-400.00% (-0.12)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OABI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 08, 2025	$1.57	$1.44	-8.28%
Mar 18, 2025	$3.19	$2.54	-20.38%
Nov 12, 2024	$4.49	$4.07	-9.35%
Aug 08, 2024	$4.29	$4.24	-1.17%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Omniab, Inc. (OABI) report earnings?

Omniab, Inc. (OABI) is schdueled to report earning on Nov 18, 2025, TBA (Confirmed).

What is Omniab, Inc. (OABI) earnings time?

Omniab, Inc. (OABI) earnings time is at Nov 18, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OABI EPS forecast?

OABI EPS forecast for the fiscal quarter 2025 (Q3) is -0.14.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing